Inducible nonviral gene expression in the treatment of osteochondral defects

Osteoarthritis and Cartilage

Volumn 12, Issue 9, 2004, Pages 711-719

  Ueblacker, Peter ^a   Wagner, B ^a   Kruger A ^a   Vogt, S ^a   DeSantis, G ^a   Kennerknecht, E ^a   Brill, T ^a   Hillemanns, M ^b   Salzmann, G M ^a   Imhoff, A B ^a   Plank, C ^a   Gansbacher B ^a   Martinek, V ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chondrocytes; Gene transfer; Tetracycline inducible gene regulation; Tissue engineering

Indexed keywords

BETA GALACTOSIDASE; DNA; DOXYCYCLINE; GROWTH FACTOR; LIPID; PLASMID VECTOR; TETRACYCLINE; TRANSACTIVATOR PROTEIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; CARTILAGE CELL; CHONDROPATHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA MODIFICATION; FEMALE; FLOW CYTOMETRY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KNEE DISEASE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RABBIT;

3T3 CELLS; ANIMALS; ANTI-BACTERIAL AGENTS; CHONDROCYTES; DOXYCYCLINE; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GROWTH SUBSTANCES; JOINTS; LAC OPERON; MICE; MICE, NUDE; RABBITS; TISSUE ENGINEERING; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSGENES;

EID: 4444349885     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2004.05.011     Document Type: Article

References (58)

1. Curl W.W. Krome J. Gordon E.S. Rushing J. Smith B.P. Poehling G.G. Cartilage injuries: a review of 31.516 knee arthroscopies Arthroscopy 13 1997 456-460
2. Martinek V. Fu F.H. Lee C.W. Huard J. Treatment of osteochondral injuries. Genetic engineering Clin Sports Med 20 2001 403-416
3. Johnson L.L. Arthroscopic abrasion arthroplasty: a review Clin Orthop 391 2001 S306-S317
4. Pridie K.H. A method of resurfacing osteoarthritic knee joints J Bone Joint Surg (Br) 41 1959 618-619
5. Steadman J.R. Rodkey W.G. Rodrigo J.J. Microfracture: surgical technique and rehabilitation to treat chondral defects Clin Orthop 391 2001 S362-S369
6. Bobic V. Autologous osteo-chondral grafts in the management of articular cartilage lesions Orthopade 28 1999 19-25
7. Imhoff A.B. Ottl G.M. Burkart A. Traub S. Autologous osteochondral transplantation on various joints Orthopade 28 1999 33-44
8. Brittberg M. Lindahl A. Nilsson A. Ohlsson C. Isaksson O. Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation [see comments] N Engl J Med 331 1994 889-895
9. Buckwalter J.A. Mankin H.J. Articular cartilage: tissue design and chondrocyte-matrix interactions Instr Course Lect 47 1998 477-486
10. Mankin H.J. The response of articular cartilage to mechanical injury J Bone Joint Surg (Am) 64 1982 460-466
11. Huard J. Yong L. Hairong P. Fu F.H. Gene therapy and tissue engineering for sports medicine J Gene Med 5 2003 93-108
12. Messner K. Gillquist J. Cartilage repair. A critical review Acta Orthop Scand 67 1996 523-529
13. Brun P. Abatangelo G. Radice M. Zacchi V. Guidolin D. Daga G.D. et al Chondrocyte aggregation and reorganization into three-dimensional scaffolds J Biomed Mater Res 46 1999 337-346
14. Hendrickson D.A. Nixon A.J. Grande D.A. Todhunter R.J. Minor R.M. Erb H. et al. Chondrocyte-fibrin matrix transplants for resurfacing extensive articular cartilage defects J Orthop Res 12 1994 485-497
15. Martinek V. Fu F.H. Huard J. Gene therapy and tissue engineering in sports medicine Phys Sports Med 28 1999 34-51
16. Osborn K.D. Trippel S.B. Mankin H.J. Growth factor stimulation of adult articular cartilage J Orthop Res 7 1989 35-42
17. Rosier R.N. O'Keefe R.J. Autocrine regulation of articular cartilage Instr Course Lect 47 1998 469-475
18. Sah R.L. Chen A.C. Grodzinsky A.J. Trippel S.B. Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants Arch Biochem Biophys 308 1994 137-147
19. Sato K. Urist M.R. Bone morphogenetic protein-induced cartilage development in tissue culture Clin Orthop 7 1984 180-187
20. Wozney J.M. Rosen V. Celeste A.J. Mitsock L.M. Whitters M.J. Kriz R.W. et al. Novel regulators of bone formation: molecular clones and activities Science 242 1988 1528-1534
21. Evans C.H. Robbins P.D. Possible orthopaedic applications of gene therapy J Bone Joint Surg (Am) 77 1995 1103-1114
22. Ikeda T. Kubo T. Nakanishi T. Arai Y. Kobayashi K. Mazda O. et al. Ex vivo gene delivery using an adenovirus vector in treatment for cartilage defects J Rheumatol 27 2000 990-996
23. Evans C.H. Robbins P.D. Gene therapy in orthopaedics Orthop Nurs 19 2000 16-22
24. Martinek V. Lattermann C. Usas A. Abramowitch S. Fu F.H. Woo S.L.-Y. et al. Enhancement of the tendon-bone integration of ACL tendon grafts with BMP-2 gene transfer: a histological and biomechanical study J Bone Joint Surg (Am) 84 2002 1123-1131
25. Mulligan R. The basic science of gene therapy Science 260 1993 926-932
26. Arai Y. Kubo T. Kobayashi K. Takeshita K. Takahashi K. Ikeda T. et al. Adenovirus vector-mediated gene transduction to chondrocytes in vitro evaluation of therapeutic efficacy of transforming growth factor-beta 1 and heat shock protein 70 gene transduction J Rheumatol 24 1997 1787-1795
27. Dinser R. Kreppel F. Zaucke F. Blank C. Paulsson M. Kochanek S. et al. Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes Histochem Cell Biol 116 2001 69-77
28. Goomer R.S. Deftos L.J. Terkeltaub R. Maris T. Lee M.C. Harwood F.L. et al. High-efficiency non-viral transfection of primary chondrocytes and perichondrial cells for ex-vivo gene therapy to repair articular cartilage defects Osteoarthritis Cartilage 9 2001 248-256
29. Madry H. Cucchiarini M. Stein U. Remberger K. Menger M.D. Kohn D. et al. Sustained transgene expression in cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid-mediated gene transfer in a gel suspension delivery system J Gene Med 5 2003 502-509
30. Alden T.D. Pittman D.D. Hankins G.R. Beres E.J. Engh J.A. Das S. et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector Hum Gene Ther 10 1999 2245-2253
31. Bobacz K. Gruber R. Soleiman A. Graninger W.B. Luyten F.P. Erlacher L. Cartilage-derived morphogenetic protein-1 and 2 are endogenously expressed in healthy and osteoarthritic human articular chondrocytes and stimulate matrix synthesis Osteoarthritis Cartilage 10 2002 394-401
32. Gooch K.J. Blunk T. Courter D.L. Sieminski A.L. Vunjak-Novakovic G. Freed L.E. Bone morphogenetic proteins-2, 12, and 13 modulate in vitro development of engineered cartilage Tissue Eng 8 2002 591-601
33. Morales T.I. Roberts A.B. Transforming growth factor β regulates the metabolism of proteoglycans in bovine cartilage organ cultures J Biol Chem 263 1988 12828-12831
34. Crystal R.G. Transfer of genes to humans: early lessons and obstacles to success Science 270 1995 404-410
35. Mills A.A. Changing colors in mice: an inducible system that delivers Genes Dev 15 2001 1461-1467
36. Gossen M. Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters Proc Natl Acad Sci USA 89 1992 5547-5551
37. Gossen M. Freundlieb S. Bender G. Muller G. Hillen W. Bujard H. Transcriptional activation by tetracyclines in mammalian cells Science 268 1995 1766-1769
38. Lamartina S. Silvi L. Roscilli G. Casimiro D. Simon A.J. Davies M.E. et al. Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline mice and non-human primates Mol Ther 7 2003 271-280
39. Howe J.R. Skryabin B.V. Belcher S.M. Zerillo C.A. Schmauss C. The responsiveness of a tetracycline-sensitive expression system differs in different cell lines J Biol Chem 270 1995 14168-14174
40. Furth P.A. St Onge L. Boger H. Gruss P. Gossen M. Kistner A. et al Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter Proc Natl Acad Sci USA 91 1994 9302-9306
41. Shockett P. Difilippantonio M. Hellman N. Schatz D.G. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice Proc Natl Acad Sci USA 92 1995 6522-6526
42. Chang M.A. Horner J.W. Conklin B.R. DePinho R.A. Bok D. Zack D.J. Tetracycline-inducible system for photoreceptor-specific gene expression Invest Ophtalmol Vis Sci 41 2000 4282-4287
43. Fishman G.I. Kaplan M.L. Buttrick P.M. Tetracycline-regulated cardiac gene expression in vivo J Clin Invest 93 1994 1864-1868
44. Haberman R.P. McCown T.J. Samulski R.J. Inducible long-term gene expression in brain with adeno-associated virus gene transfer Gene Ther 5 1998 1604-1611
45. Mansuy M.I. Winder D.G. Moallem T.M. Osman M. Mayford M. Hawkins R.D. et al. Inducible and reversible gene expression with the rtTA System for the study of memory Neuron 21 1998 257-265
46. Dhawan J. Rando T.A. Elson S.L. Bujard H. Blau H.M. Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle Somat Cell Mol Genet 21 1995 233-240
47. Lamartina S. Roscilli G. Rinaudo C.D. Sporeno E. Silvi L. Hillen W. et al. Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators Hum Gene Ther 13 2002 199-210
48. Urlinger S. Baron U. Thellmann M. Hasan M.T. Bujard H. Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity Proc Natl Acad Sci USA 97 2000 7963-7968
49. s-M2 shows a tight control of gene expression in vitro and in vivo Gene Ther 10 2003 459-466
50. DuBridge R.B. Tang P. Hsia H.C. Leong P.M. Miller J.H. Calos M.P. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system Mol Cell Biol 7 1987 379-387
51. Hantzopoulos P.A. Sullenger B.A. Ungers G. Gilboa E. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector Proc Natl Sci USA 86 1989 3519-3523
52. Nolan G.P. Fiering S. Nicolas J.F. Herzenberg L.A. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-d-galactosidase activity after transduction of Escherichia coli LacZ Proc Natl Acad Sci USA 85 1988 2603-2607
53. Krüger A. Schirrmacher V. von Hoegen P. Scattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells Int J Cancer 58 1994 275-284
54. Goodman G. The pharmacological basis of therapeutics Antimicrobial agents 10th edn 2001 McGraw-Hill New York p. 1242
55. Baragi V.M. Renkiewicz R.R. Qiu L. Brammer D. Riley J.M. Sigler R.E. et al. Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo Osteoarthritis Cartilage 5 1997 275-282
56. Toolan B.C. Frenkel S.R. Pachence J.M. Yalowitz L. Alexander H. Effects of growth factor enhanced culture on a chondrocyte collagen implant for cartilage repair J Biomed Mater Res 31 1996 273-280
57. Hoerr I. Obst R. Rammensee H.G. Jung G. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies Eur J Immunol 30 2000 1-7
58. Menoret S. Aubert D. Tesson L. Braudeau C. Pichard V. Ferry N. et al. LacZ transgenic rats tolerant for beta-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene Hum Gene Ther 13 2002 1383-1390